nodes	percent_of_prediction	percent_of_DWPC	metapath
Bepridil—CYP2D6—Niacin—atherosclerosis	0.0632	0.149	CbGbCtD
Bepridil—ABCB1—Ezetimibe—atherosclerosis	0.057	0.134	CbGbCtD
Bepridil—ABCB1—Simvastatin—atherosclerosis	0.053	0.125	CbGbCtD
Bepridil—ABCB1—Lovastatin—atherosclerosis	0.0519	0.122	CbGbCtD
Bepridil—ABCB1—Pravastatin—atherosclerosis	0.0519	0.122	CbGbCtD
Bepridil—CYP2D6—Simvastatin—atherosclerosis	0.0499	0.118	CbGbCtD
Bepridil—CYP2D6—Lovastatin—atherosclerosis	0.0489	0.115	CbGbCtD
Bepridil—CYP2D6—Pravastatin—atherosclerosis	0.0489	0.115	CbGbCtD
Bepridil—Loss of libido—Lovastatin—atherosclerosis	0.00692	0.0276	CcSEcCtD
Bepridil—Loss of libido—Simvastatin—atherosclerosis	0.00647	0.0258	CcSEcCtD
Bepridil—Loss of libido—Pravastatin—atherosclerosis	0.00585	0.0234	CcSEcCtD
Bepridil—Gastrointestinal symptom NOS—Niacin—atherosclerosis	0.00467	0.0186	CcSEcCtD
Bepridil—Respiratory tract infection—Pravastatin—atherosclerosis	0.0043	0.0172	CcSEcCtD
Bepridil—TNNC1—connective tissue—atherosclerosis	0.00371	0.051	CbGeAlD
Bepridil—TNNC1—cardiovascular system—atherosclerosis	0.00323	0.0444	CbGeAlD
Bepridil—CALM2—artery—atherosclerosis	0.00318	0.0436	CbGeAlD
Bepridil—CALM1—artery—atherosclerosis	0.00316	0.0434	CbGeAlD
Bepridil—PDE1B—adipose tissue—atherosclerosis	0.00297	0.0408	CbGeAlD
Bepridil—TNNC1—adipose tissue—atherosclerosis	0.00285	0.0391	CbGeAlD
Bepridil—PDE1A—cardiovascular system—atherosclerosis	0.00282	0.0388	CbGeAlD
Bepridil—CALM2—endothelium—atherosclerosis	0.00268	0.0369	CbGeAlD
Bepridil—CALM1—endothelium—atherosclerosis	0.00267	0.0367	CbGeAlD
Bepridil—Antazoline—HRH1—atherosclerosis	0.00263	0.268	CrCbGaD
Bepridil—KCNQ1—cardiovascular system—atherosclerosis	0.00262	0.036	CbGeAlD
Bepridil—PDE1A—adipose tissue—atherosclerosis	0.00249	0.0342	CbGeAlD
Bepridil—CALM2—blood vessel—atherosclerosis	0.00248	0.034	CbGeAlD
Bepridil—CALM1—blood vessel—atherosclerosis	0.00246	0.0338	CbGeAlD
Bepridil—Arthritis—Lovastatin—atherosclerosis	0.00239	0.00953	CcSEcCtD
Bepridil—Influenza—Rosuvastatin—atherosclerosis	0.00237	0.00944	CcSEcCtD
Bepridil—Arthritis—Ezetimibe—atherosclerosis	0.00234	0.00934	CcSEcCtD
Bepridil—KCNQ1—adipose tissue—atherosclerosis	0.00231	0.0318	CbGeAlD
Bepridil—Arthritis—Simvastatin—atherosclerosis	0.00223	0.00891	CcSEcCtD
Bepridil—CACNA1H—cardiovascular system—atherosclerosis	0.0022	0.0303	CbGeAlD
Bepridil—Depression—Rosuvastatin—atherosclerosis	0.0021	0.00839	CcSEcCtD
Bepridil—Liver function test abnormal—Ezetimibe—atherosclerosis	0.0021	0.00838	CcSEcCtD
Bepridil—Arthritis—Niacin—atherosclerosis	0.00205	0.00818	CcSEcCtD
Bepridil—Arthritis—Pravastatin—atherosclerosis	0.00202	0.00806	CcSEcCtD
Bepridil—Gastritis—Ezetimibe—atherosclerosis	0.00201	0.00804	CcSEcCtD
Bepridil—Influenza—Lovastatin—atherosclerosis	0.002	0.008	CcSEcCtD
Bepridil—Influenza—Ezetimibe—atherosclerosis	0.00197	0.00785	CcSEcCtD
Bepridil—CACNA1C—connective tissue—atherosclerosis	0.00193	0.0265	CbGeAlD
Bepridil—Abdominal discomfort—Lovastatin—atherosclerosis	0.00192	0.00767	CcSEcCtD
Bepridil—Gastritis—Simvastatin—atherosclerosis	0.00192	0.00766	CcSEcCtD
Bepridil—Rhinitis—Rosuvastatin—atherosclerosis	0.0019	0.00758	CcSEcCtD
Bepridil—Pharyngitis—Rosuvastatin—atherosclerosis	0.00188	0.0075	CcSEcCtD
Bepridil—Erectile dysfunction—Lovastatin—atherosclerosis	0.00185	0.00737	CcSEcCtD
Bepridil—Liver function test abnormal—Niacin—atherosclerosis	0.00184	0.00734	CcSEcCtD
Bepridil—CACNA1D—cardiovascular system—atherosclerosis	0.00182	0.025	CbGeAlD
Bepridil—Erectile dysfunction—Ezetimibe—atherosclerosis	0.00181	0.00723	CcSEcCtD
Bepridil—Liver function test abnormal—Pravastatin—atherosclerosis	0.00181	0.00723	CcSEcCtD
Bepridil—Abdominal discomfort—Simvastatin—atherosclerosis	0.0018	0.00718	CcSEcCtD
Bepridil—PDE1A—liver—atherosclerosis	0.00175	0.024	CbGeAlD
Bepridil—Diphenylpyraline—HRH1—atherosclerosis	0.00173	0.177	CrCbGaD
Bepridil—Tripelennamine—HRH1—atherosclerosis	0.00173	0.177	CrCbGaD
Bepridil—Erectile dysfunction—Simvastatin—atherosclerosis	0.00173	0.00689	CcSEcCtD
Bepridil—Influenza—Niacin—atherosclerosis	0.00172	0.00687	CcSEcCtD
Bepridil—Influenza—Pravastatin—atherosclerosis	0.0017	0.00677	CcSEcCtD
Bepridil—Arrhythmia—Rosuvastatin—atherosclerosis	0.00169	0.00675	CcSEcCtD
Bepridil—CACNA1C—cardiovascular system—atherosclerosis	0.00168	0.0231	CbGeAlD
Bepridil—Angina pectoris—Niacin—atherosclerosis	0.00168	0.00669	CcSEcCtD
Bepridil—Depression—Simvastatin—atherosclerosis	0.00167	0.00665	CcSEcCtD
Bepridil—Angina pectoris—Pravastatin—atherosclerosis	0.00165	0.00659	CcSEcCtD
Bepridil—Ifenprodil—HRH1—atherosclerosis	0.00164	0.167	CrCbGaD
Bepridil—Flatulence—Rosuvastatin—atherosclerosis	0.00162	0.00648	CcSEcCtD
Bepridil—KCNQ1—liver—atherosclerosis	0.00162	0.0223	CbGeAlD
Bepridil—Erectile dysfunction—Niacin—atherosclerosis	0.00159	0.00633	CcSEcCtD
Bepridil—Pharyngitis—Ezetimibe—atherosclerosis	0.00156	0.00624	CcSEcCtD
Bepridil—Erectile dysfunction—Pravastatin—atherosclerosis	0.00156	0.00623	CcSEcCtD
Bepridil—Depression—Pravastatin—atherosclerosis	0.00151	0.00602	CcSEcCtD
Bepridil—CACNA1C—adipose tissue—atherosclerosis	0.00148	0.0203	CbGeAlD
Bepridil—Sweating—Niacin—atherosclerosis	0.00147	0.00587	CcSEcCtD
Bepridil—ATP1A1—connective tissue—atherosclerosis	0.00144	0.0198	CbGeAlD
Bepridil—Cough—Rosuvastatin—atherosclerosis	0.00144	0.00574	CcSEcCtD
Bepridil—Myalgia—Rosuvastatin—atherosclerosis	0.0014	0.0056	CcSEcCtD
Bepridil—Cyclizine—HRH1—atherosclerosis	0.0014	0.142	CrCbGaD
Bepridil—Rhinitis—Niacin—atherosclerosis	0.00138	0.00552	CcSEcCtD
Bepridil—Flatulence—Lovastatin—atherosclerosis	0.00138	0.00549	CcSEcCtD
Bepridil—CACNA1H—liver—atherosclerosis	0.00136	0.0187	CbGeAlD
Bepridil—Rhinitis—Pravastatin—atherosclerosis	0.00136	0.00543	CcSEcCtD
Bepridil—Flatulence—Ezetimibe—atherosclerosis	0.00135	0.00539	CcSEcCtD
Bepridil—Pharyngitis—Pravastatin—atherosclerosis	0.00135	0.00538	CcSEcCtD
Bepridil—Vision blurred—Lovastatin—atherosclerosis	0.00132	0.00525	CcSEcCtD
Bepridil—Tremor—Lovastatin—atherosclerosis	0.00131	0.00522	CcSEcCtD
Bepridil—Flatulence—Simvastatin—atherosclerosis	0.00129	0.00514	CcSEcCtD
Bepridil—Tinnitus—Niacin—atherosclerosis	0.00128	0.00513	CcSEcCtD
Bepridil—CALM2—connective tissue—atherosclerosis	0.00127	0.0174	CbGeAlD
Bepridil—Tinnitus—Pravastatin—atherosclerosis	0.00126	0.00505	CcSEcCtD
Bepridil—CALM1—connective tissue—atherosclerosis	0.00126	0.0174	CbGeAlD
Bepridil—Cardiac disorder—Pravastatin—atherosclerosis	0.00126	0.00503	CcSEcCtD
Bepridil—Vertigo—Lovastatin—atherosclerosis	0.00125	0.00501	CcSEcCtD
Bepridil—ATP1A1—cardiovascular system—atherosclerosis	0.00125	0.0172	CbGeAlD
Bepridil—CALM3—adipose tissue—atherosclerosis	0.00124	0.017	CbGeAlD
Bepridil—Vision blurred—Simvastatin—atherosclerosis	0.00123	0.00492	CcSEcCtD
Bepridil—Arrhythmia—Niacin—atherosclerosis	0.00123	0.00491	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00123	0.00489	CcSEcCtD
Bepridil—Tremor—Simvastatin—atherosclerosis	0.00122	0.00489	CcSEcCtD
Bepridil—Insomnia—Rosuvastatin—atherosclerosis	0.00122	0.00486	CcSEcCtD
Bepridil—Arrhythmia—Pravastatin—atherosclerosis	0.00121	0.00484	CcSEcCtD
Bepridil—Palpitations—Ezetimibe—atherosclerosis	0.00121	0.00483	CcSEcCtD
Bepridil—Paraesthesia—Rosuvastatin—atherosclerosis	0.00121	0.00482	CcSEcCtD
Bepridil—Cough—Ezetimibe—atherosclerosis	0.0012	0.00477	CcSEcCtD
Bepridil—Myalgia—Lovastatin—atherosclerosis	0.00119	0.00475	CcSEcCtD
Bepridil—Anxiety—Lovastatin—atherosclerosis	0.00118	0.00473	CcSEcCtD
Bepridil—Dyspepsia—Rosuvastatin—atherosclerosis	0.00118	0.00473	CcSEcCtD
Bepridil—Hypertension—Ezetimibe—atherosclerosis	0.00118	0.00472	CcSEcCtD
Bepridil—Flatulence—Niacin—atherosclerosis	0.00118	0.00472	CcSEcCtD
Bepridil—Tension—Niacin—atherosclerosis	0.00118	0.0047	CcSEcCtD
Bepridil—Vertigo—Simvastatin—atherosclerosis	0.00117	0.00469	CcSEcCtD
Bepridil—Myalgia—Ezetimibe—atherosclerosis	0.00117	0.00466	CcSEcCtD
Bepridil—Nervousness—Niacin—atherosclerosis	0.00117	0.00465	CcSEcCtD
Bepridil—Flatulence—Pravastatin—atherosclerosis	0.00116	0.00465	CcSEcCtD
Bepridil—Dry mouth—Lovastatin—atherosclerosis	0.00116	0.00464	CcSEcCtD
Bepridil—Tension—Pravastatin—atherosclerosis	0.00116	0.00463	CcSEcCtD
Bepridil—Constipation—Rosuvastatin—atherosclerosis	0.00115	0.00459	CcSEcCtD
Bepridil—Pain—Rosuvastatin—atherosclerosis	0.00115	0.00459	CcSEcCtD
Bepridil—Nervousness—Pravastatin—atherosclerosis	0.00115	0.00458	CcSEcCtD
Bepridil—Dry mouth—Ezetimibe—atherosclerosis	0.00114	0.00455	CcSEcCtD
Bepridil—Vision blurred—Niacin—atherosclerosis	0.00113	0.00451	CcSEcCtD
Bepridil—CACNA1D—liver—atherosclerosis	0.00113	0.0154	CbGeAlD
Bepridil—Vision blurred—Pravastatin—atherosclerosis	0.00111	0.00444	CcSEcCtD
Bepridil—Myalgia—Simvastatin—atherosclerosis	0.00111	0.00444	CcSEcCtD
Bepridil—Anxiety—Simvastatin—atherosclerosis	0.00111	0.00442	CcSEcCtD
Bepridil—Tremor—Pravastatin—atherosclerosis	0.00111	0.00442	CcSEcCtD
Bepridil—ATP1A1—adipose tissue—atherosclerosis	0.00111	0.0152	CbGeAlD
Bepridil—CALM2—cardiovascular system—atherosclerosis	0.0011	0.0152	CbGeAlD
Bepridil—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.0011	0.00439	CcSEcCtD
Bepridil—CALM1—cardiovascular system—atherosclerosis	0.0011	0.0151	CbGeAlD
Bepridil—Anorexia—Lovastatin—atherosclerosis	0.00109	0.00434	CcSEcCtD
Bepridil—Vertigo—Niacin—atherosclerosis	0.00108	0.0043	CcSEcCtD
Bepridil—Syncope—Niacin—atherosclerosis	0.00108	0.00429	CcSEcCtD
Bepridil—Oedema—Simvastatin—atherosclerosis	0.00107	0.00426	CcSEcCtD
Bepridil—Abdominal pain—Rosuvastatin—atherosclerosis	0.00106	0.00424	CcSEcCtD
Bepridil—Vertigo—Pravastatin—atherosclerosis	0.00106	0.00424	CcSEcCtD
Bepridil—Palpitations—Niacin—atherosclerosis	0.00106	0.00423	CcSEcCtD
Bepridil—Loss of consciousness—Niacin—atherosclerosis	0.00105	0.00421	CcSEcCtD
Bepridil—Cough—Niacin—atherosclerosis	0.00105	0.00418	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00104	0.00415	CcSEcCtD
Bepridil—Insomnia—Lovastatin—atherosclerosis	0.00103	0.00412	CcSEcCtD
Bepridil—Cough—Pravastatin—atherosclerosis	0.00103	0.00411	CcSEcCtD
Bepridil—Paraesthesia—Lovastatin—atherosclerosis	0.00102	0.00409	CcSEcCtD
Bepridil—Myalgia—Niacin—atherosclerosis	0.00102	0.00408	CcSEcCtD
Bepridil—Hypertension—Pravastatin—atherosclerosis	0.00102	0.00407	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00102	0.00407	CcSEcCtD
Bepridil—Anorexia—Simvastatin—atherosclerosis	0.00102	0.00406	CcSEcCtD
Bepridil—Dyspnoea—Lovastatin—atherosclerosis	0.00102	0.00406	CcSEcCtD
Bepridil—Insomnia—Ezetimibe—atherosclerosis	0.00101	0.00404	CcSEcCtD
Bepridil—Myalgia—Pravastatin—atherosclerosis	0.00101	0.00401	CcSEcCtD
Bepridil—Paraesthesia—Ezetimibe—atherosclerosis	0.001	0.00401	CcSEcCtD
Bepridil—Dyspepsia—Lovastatin—atherosclerosis	0.001	0.00401	CcSEcCtD
Bepridil—Anxiety—Pravastatin—atherosclerosis	0.001	0.004	CcSEcCtD
Bepridil—KCNH2—cardiovascular system—atherosclerosis	0.001	0.0137	CbGeAlD
Bepridil—Dry mouth—Niacin—atherosclerosis	0.000999	0.00399	CcSEcCtD
Bepridil—Dyspnoea—Ezetimibe—atherosclerosis	0.000997	0.00398	CcSEcCtD
Bepridil—Decreased appetite—Lovastatin—atherosclerosis	0.000991	0.00396	CcSEcCtD
Bepridil—Dyspepsia—Ezetimibe—atherosclerosis	0.000984	0.00393	CcSEcCtD
Bepridil—ABCB1—blood vessel—atherosclerosis	0.000984	0.0135	CbGeAlD
Bepridil—Oedema—Niacin—atherosclerosis	0.000979	0.00391	CcSEcCtD
Bepridil—Pain—Lovastatin—atherosclerosis	0.000975	0.00389	CcSEcCtD
Bepridil—Constipation—Lovastatin—atherosclerosis	0.000975	0.00389	CcSEcCtD
Bepridil—CALM2—adipose tissue—atherosclerosis	0.000974	0.0134	CbGeAlD
Bepridil—Decreased appetite—Ezetimibe—atherosclerosis	0.000972	0.00388	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000971	0.00388	CcSEcCtD
Bepridil—CALM1—adipose tissue—atherosclerosis	0.00097	0.0133	CbGeAlD
Bepridil—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000965	0.00385	CcSEcCtD
Bepridil—Asthenia—Rosuvastatin—atherosclerosis	0.000965	0.00385	CcSEcCtD
Bepridil—Insomnia—Simvastatin—atherosclerosis	0.000964	0.00385	CcSEcCtD
Bepridil—Oedema—Pravastatin—atherosclerosis	0.000964	0.00385	CcSEcCtD
Bepridil—Shock—Niacin—atherosclerosis	0.000963	0.00385	CcSEcCtD
Bepridil—Paraesthesia—Simvastatin—atherosclerosis	0.000957	0.00382	CcSEcCtD
Bepridil—Pain—Ezetimibe—atherosclerosis	0.000956	0.00382	CcSEcCtD
Bepridil—Constipation—Ezetimibe—atherosclerosis	0.000956	0.00382	CcSEcCtD
Bepridil—Dyspnoea—Simvastatin—atherosclerosis	0.000951	0.00379	CcSEcCtD
Bepridil—Hyperhidrosis—Niacin—atherosclerosis	0.000946	0.00378	CcSEcCtD
Bepridil—Dyspepsia—Simvastatin—atherosclerosis	0.000939	0.00375	CcSEcCtD
Bepridil—Anorexia—Niacin—atherosclerosis	0.000933	0.00373	CcSEcCtD
Bepridil—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000932	0.00372	CcSEcCtD
Bepridil—Hyperhidrosis—Pravastatin—atherosclerosis	0.000932	0.00372	CcSEcCtD
Bepridil—Decreased appetite—Simvastatin—atherosclerosis	0.000927	0.0037	CcSEcCtD
Bepridil—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00092	0.00367	CcSEcCtD
Bepridil—Diarrhoea—Rosuvastatin—atherosclerosis	0.00092	0.00367	CcSEcCtD
Bepridil—Anorexia—Pravastatin—atherosclerosis	0.000919	0.00367	CcSEcCtD
Bepridil—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000914	0.00365	CcSEcCtD
Bepridil—Constipation—Simvastatin—atherosclerosis	0.000912	0.00364	CcSEcCtD
Bepridil—Pain—Simvastatin—atherosclerosis	0.000912	0.00364	CcSEcCtD
Bepridil—Abdominal pain—Lovastatin—atherosclerosis	0.000901	0.0036	CcSEcCtD
Bepridil—Body temperature increased—Lovastatin—atherosclerosis	0.000901	0.0036	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000892	0.00356	CcSEcCtD
Bepridil—Dizziness—Rosuvastatin—atherosclerosis	0.000889	0.00355	CcSEcCtD
Bepridil—Insomnia—Niacin—atherosclerosis	0.000885	0.00353	CcSEcCtD
Bepridil—Abdominal pain—Ezetimibe—atherosclerosis	0.000884	0.00353	CcSEcCtD
Bepridil—Body temperature increased—Ezetimibe—atherosclerosis	0.000884	0.00353	CcSEcCtD
Bepridil—Paraesthesia—Niacin—atherosclerosis	0.000879	0.00351	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000878	0.00351	CcSEcCtD
Bepridil—Dyspnoea—Niacin—atherosclerosis	0.000873	0.00348	CcSEcCtD
Bepridil—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000872	0.00348	CcSEcCtD
Bepridil—Insomnia—Pravastatin—atherosclerosis	0.000872	0.00348	CcSEcCtD
Bepridil—Somnolence—Niacin—atherosclerosis	0.00087	0.00347	CcSEcCtD
Bepridil—CALM3—liver—atherosclerosis	0.00087	0.0119	CbGeAlD
Bepridil—Paraesthesia—Pravastatin—atherosclerosis	0.000866	0.00346	CcSEcCtD
Bepridil—Dyspepsia—Niacin—atherosclerosis	0.000862	0.00344	CcSEcCtD
Bepridil—Dyspnoea—Pravastatin—atherosclerosis	0.000859	0.00343	CcSEcCtD
Bepridil—Decreased appetite—Niacin—atherosclerosis	0.000851	0.0034	CcSEcCtD
Bepridil—Dyspepsia—Pravastatin—atherosclerosis	0.000848	0.00339	CcSEcCtD
Bepridil—Rash—Rosuvastatin—atherosclerosis	0.000848	0.00339	CcSEcCtD
Bepridil—Dermatitis—Rosuvastatin—atherosclerosis	0.000847	0.00338	CcSEcCtD
Bepridil—Gastrointestinal disorder—Niacin—atherosclerosis	0.000845	0.00337	CcSEcCtD
Bepridil—Abdominal pain—Simvastatin—atherosclerosis	0.000843	0.00336	CcSEcCtD
Bepridil—Body temperature increased—Simvastatin—atherosclerosis	0.000843	0.00336	CcSEcCtD
Bepridil—Headache—Rosuvastatin—atherosclerosis	0.000843	0.00336	CcSEcCtD
Bepridil—Decreased appetite—Pravastatin—atherosclerosis	0.000838	0.00335	CcSEcCtD
Bepridil—Pain—Niacin—atherosclerosis	0.000837	0.00334	CcSEcCtD
Bepridil—Pain—Pravastatin—atherosclerosis	0.000824	0.00329	CcSEcCtD
Bepridil—Constipation—Pravastatin—atherosclerosis	0.000824	0.00329	CcSEcCtD
Bepridil—Asthenia—Lovastatin—atherosclerosis	0.000818	0.00326	CcSEcCtD
Bepridil—Asthenia—Ezetimibe—atherosclerosis	0.000802	0.0032	CcSEcCtD
Bepridil—Gastrointestinal pain—Niacin—atherosclerosis	0.000801	0.0032	CcSEcCtD
Bepridil—Nausea—Rosuvastatin—atherosclerosis	0.000799	0.00319	CcSEcCtD
Bepridil—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000788	0.00315	CcSEcCtD
Bepridil—Diarrhoea—Lovastatin—atherosclerosis	0.00078	0.00311	CcSEcCtD
Bepridil—ATP1A1—liver—atherosclerosis	0.000776	0.0107	CbGeAlD
Bepridil—Body temperature increased—Niacin—atherosclerosis	0.000774	0.00309	CcSEcCtD
Bepridil—Abdominal pain—Niacin—atherosclerosis	0.000774	0.00309	CcSEcCtD
Bepridil—Asthenia—Simvastatin—atherosclerosis	0.000765	0.00305	CcSEcCtD
Bepridil—Diarrhoea—Ezetimibe—atherosclerosis	0.000765	0.00305	CcSEcCtD
Bepridil—Body temperature increased—Pravastatin—atherosclerosis	0.000762	0.00304	CcSEcCtD
Bepridil—Abdominal pain—Pravastatin—atherosclerosis	0.000762	0.00304	CcSEcCtD
Bepridil—Dizziness—Lovastatin—atherosclerosis	0.000754	0.00301	CcSEcCtD
Bepridil—Dizziness—Ezetimibe—atherosclerosis	0.000739	0.00295	CcSEcCtD
Bepridil—Diarrhoea—Simvastatin—atherosclerosis	0.000729	0.00291	CcSEcCtD
Bepridil—Rash—Lovastatin—atherosclerosis	0.000719	0.00287	CcSEcCtD
Bepridil—Dermatitis—Lovastatin—atherosclerosis	0.000718	0.00287	CcSEcCtD
Bepridil—Headache—Lovastatin—atherosclerosis	0.000714	0.00285	CcSEcCtD
Bepridil—Dizziness—Simvastatin—atherosclerosis	0.000705	0.00281	CcSEcCtD
Bepridil—Rash—Ezetimibe—atherosclerosis	0.000705	0.00281	CcSEcCtD
Bepridil—Dermatitis—Ezetimibe—atherosclerosis	0.000704	0.00281	CcSEcCtD
Bepridil—Asthenia—Niacin—atherosclerosis	0.000702	0.0028	CcSEcCtD
Bepridil—Headache—Ezetimibe—atherosclerosis	0.0007	0.0028	CcSEcCtD
Bepridil—Asthenia—Pravastatin—atherosclerosis	0.000692	0.00276	CcSEcCtD
Bepridil—Diphenhydramine—HRH1—atherosclerosis	0.000684	0.0697	CrCbGaD
Bepridil—CALM2—liver—atherosclerosis	0.000683	0.00938	CbGeAlD
Bepridil—CALM1—liver—atherosclerosis	0.00068	0.00934	CbGeAlD
Bepridil—Nausea—Lovastatin—atherosclerosis	0.000677	0.0027	CcSEcCtD
Bepridil—Rash—Simvastatin—atherosclerosis	0.000672	0.00268	CcSEcCtD
Bepridil—Dermatitis—Simvastatin—atherosclerosis	0.000672	0.00268	CcSEcCtD
Bepridil—Diarrhoea—Niacin—atherosclerosis	0.00067	0.00267	CcSEcCtD
Bepridil—Headache—Simvastatin—atherosclerosis	0.000668	0.00267	CcSEcCtD
Bepridil—Nausea—Ezetimibe—atherosclerosis	0.000664	0.00265	CcSEcCtD
Bepridil—Diarrhoea—Pravastatin—atherosclerosis	0.00066	0.00263	CcSEcCtD
Bepridil—Dizziness—Niacin—atherosclerosis	0.000647	0.00258	CcSEcCtD
Bepridil—Dizziness—Pravastatin—atherosclerosis	0.000637	0.00254	CcSEcCtD
Bepridil—Nausea—Simvastatin—atherosclerosis	0.000633	0.00253	CcSEcCtD
Bepridil—Rash—Niacin—atherosclerosis	0.000617	0.00246	CcSEcCtD
Bepridil—Dermatitis—Niacin—atherosclerosis	0.000617	0.00246	CcSEcCtD
Bepridil—Headache—Niacin—atherosclerosis	0.000613	0.00245	CcSEcCtD
Bepridil—Rash—Pravastatin—atherosclerosis	0.000608	0.00243	CcSEcCtD
Bepridil—Dermatitis—Pravastatin—atherosclerosis	0.000607	0.00242	CcSEcCtD
Bepridil—Headache—Pravastatin—atherosclerosis	0.000604	0.00241	CcSEcCtD
Bepridil—Nausea—Niacin—atherosclerosis	0.000582	0.00232	CcSEcCtD
Bepridil—Nausea—Pravastatin—atherosclerosis	0.000573	0.00229	CcSEcCtD
Bepridil—ABCB1—cardiovascular system—atherosclerosis	0.000439	0.00603	CbGeAlD
Bepridil—ABCB1—adipose tissue—atherosclerosis	0.000387	0.00532	CbGeAlD
Bepridil—CYP2D6—liver—atherosclerosis	0.000377	0.00518	CbGeAlD
Bepridil—ABCB1—liver—atherosclerosis	0.000271	0.00373	CbGeAlD
Bepridil—PDE1B—Signaling Pathways—TGFB1—atherosclerosis	1.19e-05	4.92e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—APOB—atherosclerosis	1.19e-05	4.92e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IGF2—atherosclerosis	1.19e-05	4.9e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IGF2—atherosclerosis	1.19e-05	4.9e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—MTHFR—atherosclerosis	1.19e-05	4.9e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—MTHFR—atherosclerosis	1.19e-05	4.9e-05	CbGpPWpGaD
Bepridil—PDE1B—Disease—AKT1—atherosclerosis	1.18e-05	4.89e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—EDN1—atherosclerosis	1.17e-05	4.84e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—AGT—atherosclerosis	1.17e-05	4.81e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CCL5—atherosclerosis	1.16e-05	4.81e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—INS—atherosclerosis	1.16e-05	4.81e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PPARA—atherosclerosis	1.16e-05	4.8e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PPARA—atherosclerosis	1.16e-05	4.8e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—APOB—atherosclerosis	1.15e-05	4.76e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—APOB—atherosclerosis	1.15e-05	4.76e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—APOE—atherosclerosis	1.14e-05	4.71e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—LPL—atherosclerosis	1.14e-05	4.7e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—EDN1—atherosclerosis	1.14e-05	4.69e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—EDN1—atherosclerosis	1.14e-05	4.69e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—CAV1—atherosclerosis	1.13e-05	4.67e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—HMOX1—atherosclerosis	1.13e-05	4.66e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—APOA1—atherosclerosis	1.13e-05	4.66e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—AGT—atherosclerosis	1.13e-05	4.65e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—AGT—atherosclerosis	1.13e-05	4.65e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CCL5—atherosclerosis	1.13e-05	4.65e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CCL5—atherosclerosis	1.13e-05	4.65e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—INS—atherosclerosis	1.13e-05	4.65e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—INS—atherosclerosis	1.13e-05	4.65e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PRKCG—atherosclerosis	1.11e-05	4.57e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—APOE—atherosclerosis	1.1e-05	4.56e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—APOE—atherosclerosis	1.1e-05	4.56e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—LPL—atherosclerosis	1.1e-05	4.55e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—LPL—atherosclerosis	1.1e-05	4.55e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—CAV1—atherosclerosis	1.09e-05	4.52e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—CAV1—atherosclerosis	1.09e-05	4.52e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—APOA1—atherosclerosis	1.09e-05	4.5e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—APOA1—atherosclerosis	1.09e-05	4.5e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—APOB—atherosclerosis	1.08e-05	4.46e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—SPP1—atherosclerosis	1.08e-05	4.45e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—CXCL8—atherosclerosis	1.07e-05	4.43e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PRKCG—atherosclerosis	1.07e-05	4.42e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PRKCG—atherosclerosis	1.07e-05	4.42e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—SERPINE1—atherosclerosis	1.07e-05	4.41e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.06e-05	4.39e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—IFNG—atherosclerosis	1.06e-05	4.35e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—GSTM1—atherosclerosis	1.05e-05	4.34e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—SPP1—atherosclerosis	1.04e-05	4.31e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—SPP1—atherosclerosis	1.04e-05	4.31e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—CXCL8—atherosclerosis	1.04e-05	4.29e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—CXCL8—atherosclerosis	1.04e-05	4.29e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—SERPINE1—atherosclerosis	1.03e-05	4.27e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—SERPINE1—atherosclerosis	1.03e-05	4.27e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—LPL—atherosclerosis	1.03e-05	4.26e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PIK3CG—atherosclerosis	1.03e-05	4.25e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—NOS3—atherosclerosis	1.02e-05	4.21e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—IFNG—atherosclerosis	1.02e-05	4.21e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—IFNG—atherosclerosis	1.02e-05	4.21e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—APOB—atherosclerosis	1.02e-05	4.2e-05	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—AKT1—atherosclerosis	1.02e-05	4.19e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—GPX1—atherosclerosis	1.01e-05	4.16e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PDGFB—atherosclerosis	9.98e-06	4.12e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PIK3CG—atherosclerosis	9.97e-06	4.11e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PIK3CG—atherosclerosis	9.97e-06	4.11e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PPARG—atherosclerosis	9.94e-06	4.1e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—GSTM1—atherosclerosis	9.91e-06	4.09e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—NOS3—atherosclerosis	9.88e-06	4.08e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—NOS3—atherosclerosis	9.88e-06	4.08e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—IL6—atherosclerosis	9.83e-06	4.06e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—CD36—atherosclerosis	9.81e-06	4.05e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—INS—atherosclerosis	9.75e-06	4.02e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—AGT—atherosclerosis	9.74e-06	4.02e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—LPL—atherosclerosis	9.73e-06	4.01e-05	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—AKT1—atherosclerosis	9.7e-06	4e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PDGFB—atherosclerosis	9.65e-06	3.98e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PDGFB—atherosclerosis	9.65e-06	3.98e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PPARG—atherosclerosis	9.62e-06	3.97e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PPARG—atherosclerosis	9.62e-06	3.97e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—APOE—atherosclerosis	9.55e-06	3.94e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—LEP—atherosclerosis	9.55e-06	3.94e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—GPX1—atherosclerosis	9.49e-06	3.92e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—IL6—atherosclerosis	9.46e-06	3.9e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CAV1—atherosclerosis	9.46e-06	3.9e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—APOA1—atherosclerosis	9.44e-06	3.89e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—INS—atherosclerosis	9.43e-06	3.89e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—INS—atherosclerosis	9.43e-06	3.89e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—AGT—atherosclerosis	9.42e-06	3.89e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—AGT—atherosclerosis	9.42e-06	3.89e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—IL1B—atherosclerosis	9.41e-06	3.88e-05	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—AKT1—atherosclerosis	9.38e-06	3.87e-05	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—AKT1—atherosclerosis	9.38e-06	3.87e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—PTGS2—atherosclerosis	9.34e-06	3.85e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—MTHFR—atherosclerosis	9.29e-06	3.83e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—CD36—atherosclerosis	9.24e-06	3.81e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—APOE—atherosclerosis	9.23e-06	3.81e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—LEP—atherosclerosis	9.23e-06	3.81e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—APOE—atherosclerosis	9.23e-06	3.81e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—LEP—atherosclerosis	9.23e-06	3.81e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—IL6—atherosclerosis	9.15e-06	3.78e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—IL6—atherosclerosis	9.15e-06	3.78e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CAV1—atherosclerosis	9.15e-06	3.78e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CAV1—atherosclerosis	9.15e-06	3.78e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—APOA1—atherosclerosis	9.13e-06	3.77e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—APOA1—atherosclerosis	9.13e-06	3.77e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PPARA—atherosclerosis	9.12e-06	3.76e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—ESR1—atherosclerosis	9.11e-06	3.76e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—IL1B—atherosclerosis	9.11e-06	3.76e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL1B—atherosclerosis	9.11e-06	3.76e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—AKT1—atherosclerosis	9.07e-06	3.74e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—PTGS2—atherosclerosis	9.04e-06	3.73e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—PTGS2—atherosclerosis	9.04e-06	3.73e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—F2—atherosclerosis	9e-06	3.71e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—IL6—atherosclerosis	8.99e-06	3.71e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—ALB—atherosclerosis	8.94e-06	3.69e-05	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—AKT1—atherosclerosis	8.92e-06	3.68e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—AGT—atherosclerosis	8.83e-06	3.64e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—ESR1—atherosclerosis	8.82e-06	3.64e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—ESR1—atherosclerosis	8.82e-06	3.64e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—NFKB1—atherosclerosis	8.78e-06	3.62e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—MTHFR—atherosclerosis	8.76e-06	3.61e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—AKT1—atherosclerosis	8.73e-06	3.6e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—F2—atherosclerosis	8.71e-06	3.59e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—F2—atherosclerosis	8.71e-06	3.59e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—APOE—atherosclerosis	8.65e-06	3.57e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—ALB—atherosclerosis	8.65e-06	3.57e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—ALB—atherosclerosis	8.65e-06	3.57e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—MAPK8—atherosclerosis	8.63e-06	3.56e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PIK3CG—atherosclerosis	8.62e-06	3.56e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PPARA—atherosclerosis	8.59e-06	3.55e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—CAV1—atherosclerosis	8.57e-06	3.54e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—APOA1—atherosclerosis	8.55e-06	3.53e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—NOS3—atherosclerosis	8.55e-06	3.53e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—NFKB1—atherosclerosis	8.49e-06	3.5e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—NFKB1—atherosclerosis	8.49e-06	3.5e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—AKT1—atherosclerosis	8.44e-06	3.48e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—AKT1—atherosclerosis	8.44e-06	3.48e-05	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—AKT1—atherosclerosis	8.38e-06	3.46e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—MAPK8—atherosclerosis	8.35e-06	3.45e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—MAPK8—atherosclerosis	8.35e-06	3.45e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PIK3CG—atherosclerosis	8.33e-06	3.44e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PIK3CG—atherosclerosis	8.33e-06	3.44e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—AGT—atherosclerosis	8.32e-06	3.43e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—AKT1—atherosclerosis	8.29e-06	3.42e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—NOS3—atherosclerosis	8.27e-06	3.41e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—NOS3—atherosclerosis	8.27e-06	3.41e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—MAPK3—atherosclerosis	8.25e-06	3.4e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—INS—atherosclerosis	8.16e-06	3.37e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—APOE—atherosclerosis	8.15e-06	3.36e-05	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—AKT1—atherosclerosis	8.11e-06	3.35e-05	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—AKT1—atherosclerosis	8.11e-06	3.35e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—CAV1—atherosclerosis	8.08e-06	3.33e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—APOA1—atherosclerosis	8.06e-06	3.33e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CCL2—atherosclerosis	8.02e-06	3.31e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—MAPK3—atherosclerosis	7.98e-06	3.29e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—MAPK3—atherosclerosis	7.98e-06	3.29e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—STAT3—atherosclerosis	7.89e-06	3.26e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—INS—atherosclerosis	7.89e-06	3.26e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—INS—atherosclerosis	7.89e-06	3.26e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IGF1—atherosclerosis	7.89e-06	3.26e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PTGS2—atherosclerosis	7.82e-06	3.23e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PIK3CG—atherosclerosis	7.81e-06	3.22e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CCL2—atherosclerosis	7.76e-06	3.2e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CCL2—atherosclerosis	7.76e-06	3.2e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—STAT3—atherosclerosis	7.63e-06	3.15e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—STAT3—atherosclerosis	7.63e-06	3.15e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IGF1—atherosclerosis	7.63e-06	3.15e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IGF1—atherosclerosis	7.63e-06	3.15e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PTGS2—atherosclerosis	7.57e-06	3.12e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PTGS2—atherosclerosis	7.57e-06	3.12e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—MAPK3—atherosclerosis	7.54e-06	3.11e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PPARG—atherosclerosis	7.54e-06	3.11e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—SERPINE1—atherosclerosis	7.49e-06	3.09e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—INS—atherosclerosis	7.39e-06	3.05e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PIK3CG—atherosclerosis	7.36e-06	3.04e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—MAPK3—atherosclerosis	7.29e-06	3.01e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—MAPK3—atherosclerosis	7.29e-06	3.01e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—STAT3—atherosclerosis	7.29e-06	3.01e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—SERPINE1—atherosclerosis	7.25e-06	2.99e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—SERPINE1—atherosclerosis	7.25e-06	2.99e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—NOS3—atherosclerosis	7.15e-06	2.95e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PPARG—atherosclerosis	7.1e-06	2.93e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—STAT3—atherosclerosis	7.05e-06	2.91e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—STAT3—atherosclerosis	7.05e-06	2.91e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—INS—atherosclerosis	6.97e-06	2.87e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—MAPK3—atherosclerosis	6.96e-06	2.87e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—NOS3—atherosclerosis	6.92e-06	2.85e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—NOS3—atherosclerosis	6.92e-06	2.85e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—ALB—atherosclerosis	6.78e-06	2.8e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—TGFB1—atherosclerosis	6.75e-06	2.79e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—MAPK3—atherosclerosis	6.73e-06	2.78e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—MAPK3—atherosclerosis	6.73e-06	2.78e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—TGFB1—atherosclerosis	6.53e-06	2.7e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—TGFB1—atherosclerosis	6.53e-06	2.7e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—NOS3—atherosclerosis	6.48e-06	2.67e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—ALB—atherosclerosis	6.39e-06	2.63e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CXCL8—atherosclerosis	6.34e-06	2.62e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CXCL8—atherosclerosis	6.14e-06	2.53e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CXCL8—atherosclerosis	6.14e-06	2.53e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—NOS3—atherosclerosis	6.11e-06	2.52e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—IL6—atherosclerosis	6.03e-06	2.49e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PTGS2—atherosclerosis	5.93e-06	2.45e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—IL6—atherosclerosis	5.84e-06	2.41e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—IL6—atherosclerosis	5.84e-06	2.41e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MMP9—atherosclerosis	5.74e-06	2.37e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—NFKB1—atherosclerosis	5.68e-06	2.34e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PTGS2—atherosclerosis	5.59e-06	2.31e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MAPK8—atherosclerosis	5.58e-06	2.3e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—AKT1—atherosclerosis	5.57e-06	2.3e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MMP9—atherosclerosis	5.55e-06	2.29e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MMP9—atherosclerosis	5.55e-06	2.29e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—IL6—atherosclerosis	5.51e-06	2.27e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—NFKB1—atherosclerosis	5.49e-06	2.27e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—NFKB1—atherosclerosis	5.49e-06	2.27e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MAPK8—atherosclerosis	5.4e-06	2.23e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MAPK8—atherosclerosis	5.4e-06	2.23e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—AKT1—atherosclerosis	5.38e-06	2.22e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—AKT1—atherosclerosis	5.38e-06	2.22e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL6—atherosclerosis	5.33e-06	2.2e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—IL6—atherosclerosis	5.33e-06	2.2e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—VEGFA—atherosclerosis	5.15e-06	2.13e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—STAT3—atherosclerosis	5.1e-06	2.11e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—IL6—atherosclerosis	5.09e-06	2.1e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—AKT1—atherosclerosis	5.08e-06	2.1e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—VEGFA—atherosclerosis	4.98e-06	2.06e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—VEGFA—atherosclerosis	4.98e-06	2.06e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—STAT3—atherosclerosis	4.94e-06	2.04e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—STAT3—atherosclerosis	4.94e-06	2.04e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—IL6—atherosclerosis	4.92e-06	2.03e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—IL6—atherosclerosis	4.92e-06	2.03e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—AKT1—atherosclerosis	4.92e-06	2.03e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—AKT1—atherosclerosis	4.92e-06	2.03e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MAPK3—atherosclerosis	4.87e-06	2.01e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TGFB1—atherosclerosis	4.73e-06	1.95e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MAPK3—atherosclerosis	4.71e-06	1.95e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MAPK3—atherosclerosis	4.71e-06	1.95e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—AKT1—atherosclerosis	4.69e-06	1.94e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TGFB1—atherosclerosis	4.57e-06	1.89e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TGFB1—atherosclerosis	4.57e-06	1.89e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—AKT1—atherosclerosis	4.54e-06	1.87e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—AKT1—atherosclerosis	4.54e-06	1.87e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—AKT1—atherosclerosis	3.93e-06	1.62e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—AKT1—atherosclerosis	3.8e-06	1.57e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—AKT1—atherosclerosis	3.8e-06	1.57e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IL6—atherosclerosis	3.56e-06	1.47e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IL6—atherosclerosis	3.45e-06	1.42e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IL6—atherosclerosis	3.45e-06	1.42e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—AKT1—atherosclerosis	3.29e-06	1.36e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—AKT1—atherosclerosis	3.18e-06	1.31e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—AKT1—atherosclerosis	3.18e-06	1.31e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—AKT1—atherosclerosis	2.98e-06	1.23e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—AKT1—atherosclerosis	2.81e-06	1.16e-05	CbGpPWpGaD
